Skip to main content
Clinical Trials/NCT02572921
NCT02572921
Unknown
Not Applicable

Evaluation of the Positive Psychotherapy to Reduce Symptoms and to Promote Happiness With Depressive Patients Compared to Cognitive-Behavioral Psychotherapy

University of Salzburg2 sites in 1 country60 target enrollmentMay 2014
ConditionsDepression

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
University of Salzburg
Enrollment
60
Locations
2
Primary Endpoint
Depressive symptoms (measured by an assessment by others)
Last Updated
10 years ago

Overview

Brief Summary

This study evaluates the effects of the Positive Psychotherapy on depressive symptoms and on happiness compared with regular cognitive behavioral therapy.

Detailed Description

Positive Psychotherapy (PPT) focuses on increasing well-being and positive emotions rather than ameliorating deficits in contrast to standard psychotherapy. A lack of positive emotions, engagement and felt meaning are typically viewed as consequences or mere correlates of depression, while the PPT suggests that these may be causal for depression. Therefore building positive emotion, engagement and meaning will alleviate depression. Thus PPT may offer a new way to treat and prevent depression. The aim of this study is to compare the effects of the Positive Psychotherapy on depressive symptoms, life satisfaction and happiness in comparison to standard cognitive behavior psychotherapy (regular cognitive behavioral therapy). 60 mildly to moderately depressed patients are randomly assigned to the Positive Psychotherapy group or the regular cognitive behavioral therapy group. Both treatments (primary intervention group and control group) are conducted in an outpatient group therapy setting with 14 sessions and a duration of 2-hours-per-week in small groups of 6 or 7 patients.

Registry
clinicaltrials.gov
Start Date
May 2014
End Date
July 2016
Last Updated
10 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Sponsor
University of Salzburg
Responsible Party
Principal Investigator
Principal Investigator

Mag. Linda Maria Furchtlehner

Principal Investigator

University of Salzburg

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of Depression (Major depressive disorder, recurrent: mild to moderate; Major depressive disorder, single episode: mild to moderate; Dysthymic disorder)
  • Patients should be between age 18 and 60

Exclusion Criteria

  • Any current treatment for depression
  • Substance related or alcohol related disorder (within the last 12 months)
  • Panic disorder
  • Manic or hypomanic disorder
  • Psychotic disorder \* refusal to participate in a 14 weeks psychotherapy treatment

Outcomes

Primary Outcomes

Depressive symptoms (measured by an assessment by others)

Time Frame: fourteen weeks

The depressive symptoms will also be measured by an assessment by others: the Montgomery Asberg Depression Scale (MADS) which consists of 10 items

Happiness (measured by a self-report-questionnaire)

Time Frame: fourteen weeks

Happiness will be assessed by a self-report-scale: the Flourishing-Scale (FS) which consists of 8 items

Happiness (measured by a self-report questionnaire)

Time Frame: fourteen weeks

Happiness will be assessed by an additional self-report-questionnaire which consists of 25 items: the Positive Psychotherapy Inventory (PPTI)

Depressive symptoms (measured by a self-report questionnaire)

Time Frame: fourteen weeks

The depressive symptoms will be assessed by a self - report questionnaire: the Beck Depression Inventory II (BDI-II) which consists of 21 items

Life satisfaction (measured by a self-report questionnaire)

Time Frame: fourteen weeks

Life-Satisfaction will be measured by a self-report-questionnaire consisting of 5 items: the Satisfaction with Life Scale (SWLS)

Secondary Outcomes

  • Life events(six months)
  • Clinical Symptoms(fourteen weeks)

Study Sites (2)

Loading locations...

Similar Trials